Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juni 2017

Planlagt Fastgjort Låst Flyttet Genmab
2.3k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • J Offline
    J Offline
    JohnW
    wrote on sidst redigeret af
    #1522

    Ved vi i hvilke indikationer man tester AXL?

    1 Reply Last reply
    0
    • J Offline
      J Offline
      JohnW
      wrote on sidst redigeret af
      #1523

      @Solsen, Dara+Tecentriq er selvfølgelig også et studie med stort markedspotentiale hvis det virker. Nu hvor vi får listet dem op, så kan jeg godt se at Genmab har mange muligheder for at kunne tilbyde noget til solide tumorer.

      1 Reply Last reply
      0
      • G Offline
        G Offline
        GeorgeBest
        wrote on sidst redigeret af
        #1524

        HuMax-AXL-ADC is an ADC targeted to AXL, a signaling molecule expressed on many solid cancers and implicated in tumor biology. HuMax-AXL-ADC is in Phase I/II clinical development for six different solid tumors. HuMax-AXL-ADC is fully owned by Genmab and the ADC technology used with HuMax-AXL- ADC was licensed from Seattle Genetics.

        1 Reply Last reply
        0
        • G Offline
          G Offline
          GeorgeBest
          wrote on sidst redigeret af
          #1525

          Ovarian Cancer
          Cervical Cancer
          Endometrial Cancer
          NSCLC
          Thyroid Cancer
          Melanoma

          1 Reply Last reply
          0
          • J Offline
            J Offline
            JohnW
            wrote on sidst redigeret af
            #1526

            Thanks GB. I start to realise that keeping track of all Genmabs studies is quite a massive challenge. 🙂

            1 Reply Last reply
            0
            • F Offline
              F Offline
              flottenschmecker
              wrote on sidst redigeret af
              #1527

              GB. Pom godkendelsen gav ikke anledning til ændring af guidance. Om den var indregnet er en helt anden ting. De fleste ceo'er er ikke begejstrede for at ændre guidance mm de er 100pct sikre på ikke at skulle omgøre det

              1 Reply Last reply
              0
              • J Offline
                J Offline
                JohnW
                wrote on sidst redigeret af
                #1528

                Interesting that the ADC is licensed from SGEN. So if it comes to market, Genmab will have to pay royalties to SGEN, I guess.

                1 Reply Last reply
                0
                • SolsenS Offline
                  SolsenS Offline
                  Solsen
                  wrote on sidst redigeret af
                  #1529

                  Iam very keen on the AXL data as I belive we can se some good data here. My gut feeling says that.

                  1 Reply Last reply
                  0
                  • M Offline
                    M Offline
                    mobbyduck1
                    wrote on sidst redigeret af
                    #1530

                    NBI oppe med 2.35%, kan give lidt medvind

                    1 Reply Last reply
                    0
                    • B Offline
                      B Offline
                      bibob
                      wrote on sidst redigeret af
                      #1531

                      Har desværre ikke selv adgang til artiklen. http://medwatch.dk/secure/Medicinal___Biotek/article9663190.ece

                      1 Reply Last reply
                      0
                      • SolsenS Offline
                        SolsenS Offline
                        Solsen
                        wrote on sidst redigeret af
                        #1532

                        https://finance.yahoo.com/news/bristol-myers-opdivo-positive-phase-145202920.html Gratis link 🙂

                        1 Reply Last reply
                        0
                        • H Offline
                          H Offline
                          Hamming
                          wrote on sidst redigeret af
                          #1533

                          Nu må der være likviditet til Tisotumab https://endpts.com/slammed-by-more-deaths-seattle-genetics-scraps-a-phiii-study-and-pulls-back-again-on-vadastuximab/

                          1 Reply Last reply
                          0
                          • SolsenS Offline
                            SolsenS Offline
                            Solsen
                            wrote on sidst redigeret af
                            #1534

                            Der var to AE i tiso forsøget grundet bleedings. Det var netop det, som Genmab frygtede mest. Blot så vi er på det rette med at AE kan være en udfordring også for tiso.

                            1 Reply Last reply
                            0
                            • M Offline
                              M Offline
                              mobbyduck1
                              wrote on sidst redigeret af
                              #1535

                              AE 5??

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                mobbyduck1
                                wrote on sidst redigeret af
                                #1536

                                dødsfald?

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  bibob
                                  wrote on sidst redigeret af
                                  #1537

                                  God morgen 🙂

                                  1 Reply Last reply
                                  0
                                  • B Offline
                                    B Offline
                                    bibob
                                    wrote on sidst redigeret af
                                    #1538

                                    Solsen : Tak for link i aftes 21.45.

                                    1 Reply Last reply
                                    0
                                    • M Offline
                                      M Offline
                                      Mayflower
                                      wrote on sidst redigeret af
                                      #1539

                                      Godmorgen 🙂

                                      1 Reply Last reply
                                      0
                                      • H Offline
                                        H Offline
                                        Her_for_at_lære
                                        wrote on sidst redigeret af
                                        #1540

                                        Godmorgen, det bliver vist en dejlig dag, solen skinner, Biotek index
                                        i US steg og futures er også positive 🙂

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #1541

                                          God morgen. 🙂

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger